propofol
Commercial- Indications
- General anesthesia, Sedation
Company intelligence / Profile preview
SEQENS
Ecully, Franceseqens.com ↗
- Ownership
- Private
- Employees
- ~3300
- Development stage
- Commercial
01
Overview
SEQENS is an integrated global leader in pharmaceutical solutions, specializing in the development, scale-up, and commercial manufacturing of active pharmaceutical ingredients (APIs), intermediates, specialty chemicals, polymers for drug delivery/RNA encapsulation/medical devices, and biotechnological products. The company serves over 1,500 customers worldwide with end-to-end support from R&D through industrialization.
- Modalities
- Small moleculeSynthetic polymerBiologicEnzyme replacement therapyPeptides
- Industry
- Drug Discovery Services
02
Drug pipeline
1 asset03
Partnerships
Works with over 1500 customers globally including major pharma/biotech companies
Beyond the preview
Go deeper on SEQENS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SEQENS.